Group One Trading, L.P. Myriad Genetics Inc Transaction History

Group One Trading, L.P.

$2.4 Billion
Q3 2024

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 09, 2023	SELL	$15.99 - $23.22 $184,540 - $267,982	-11,541 Reduced 74.0%	4,055 $65,000
Q2 2023 Aug 09, 2023	BUY	$17.56 - $23.76 $179,094 - $242,328	10,199 Added 188.98%	15,596 $361,000
Q1 2023 May 12, 2023	BUY	$15.26 - $23.75 $82,358 - $128,178	5,397 New	5,397 $125,000
Q1 2022 May 12, 2022	BUY	$22.67 - $28.01 $6,869 - $8,487	303 New	303 $8,000
Q4 2021 Feb 11, 2022	SELL	$24.13 - $32.63 $73,427 - $99,293	-3,043 Closed	0 $0
Q3 2021 Nov 12, 2021	BUY	$29.97 - $36.66 $86,913 - $106,313	2,900 Added 2027.97%	3,043 $98,000
Q2 2021 Aug 10, 2021	BUY	$25.39 - $32.61 $3,630 - $4,663	143 New	143 $4,000
Q4 2020 Feb 10, 2021	SELL	$12.16 - $19.77 $348,955 - $567,339	-28,697 Closed	0 $0
Q3 2020 Nov 12, 2020	SELL	$11.25 - $14.75 $7,875 - $10,325	-700 Reduced 2.38%	28,697 $374,000
Q2 2020 Aug 13, 2020	BUY	$10.69 - $16.49 $257,062 - $396,535	24,047 Added 449.48%	29,397 $333,000
Q1 2020 May 13, 2020	SELL	$9.78 - $29.53 $73,350 - $221,475	-7,500 Reduced 58.37%	5,350 $77,000
Q4 2019 Feb 10, 2020	BUY	$20.93 - $35.1 $30,097 - $50,473	1,438 Added 12.6%	12,850 $350,000
Q3 2019 Nov 12, 2019	BUY	$22.08 - $47.08 $208,015 - $443,540	9,421 Added 473.18%	11,412 $327,000
Q2 2019 Aug 09, 2019	BUY	$22.67 - $35.0 $45,135 - $69,685	1,991 New	1,991 $55,000
Q1 2019 May 13, 2019	SELL	$26.93 - $34.7 $65,305 - $84,147	-2,425 Closed	0 $0
Q4 2018 Feb 06, 2019	SELL	$27.23 - $45.56 $15,766 - $26,379	-579 Reduced 19.27%	2,425 $70,000
Q3 2018 Nov 08, 2018	SELL	$37.57 - $50.34 $148,551 - $199,044	-3,954 Reduced 56.83%	3,004 $138,000
Q2 2018 Aug 14, 2018	SELL	$27.75 - $40.17 $347,346 - $502,807	-12,517 Reduced 64.27%	6,958 $260,000
Q1 2018 May 11, 2018	SELL	$28.83 - $41.01 $285,359 - $405,916	-9,898 Reduced 33.7%	19,475 $575,000
Q4 2017 Feb 09, 2018	BUY	$28.45 - $37.14 $823,655 - $1.08 Million	28,951 Added 6860.43%	29,373 $1.01 Million
Q3 2017 Nov 15, 2017	SELL	$24.01 - $36.2 $755,786 - $1.14 Million	-31,478 Reduced 98.68%	422 $15,000
Q2 2017 Aug 14, 2017	BUY	N/A	31,900	31,900 $824,000

Others Institutions Holding MYGN

# of Institutions

253

Shares Held

90.5M

Call Options Held

100K

Put Options Held

34K

Black Rock Inc. New York, NY

15.2M
Shares

$208 Million
0.01% of portfolio
Vanguard Group Inc Valley Forge, PA

10.3M
Shares

$142 Million
0.01% of portfolio
Wellington Management Group LLP Boston, MA

6.72M
Shares

$92.3 Million
0.03% of portfolio
Israel Englander Millennium Management LLC | New York, Ny

5.18M
Shares

$71.1 Million
0.07% of portfolio
State Street Corp Boston, MA

4.7M
Shares

$64.6 Million
0.01% of portfolio

View Full List

About MYRIAD GENETICS INC

Ticker MYGN
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 80,634,800
Market Cap $1.11B
Description
Myriad Genetics, Inc., a genetic testing and precision medicine company, develops and commercializes genetic tests in the United States and internationally. The company offers molecular diagnostic tests for use in oncology, and women's and mental health applications. It provides MyRisk Hereditary Cancer Test, a DNA sequencing test for assessing ...

More about MYGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Group One Trading, L.P., based on Form 13F filings with the SEC.

News

Stay updated on Group One Trading, L.P. with notifications on news.

Account